(JIRE) J.P. Morgan Exchange-Traded - Overview
Etf: Equity, Developed, Markets, MSCI, EAFE
Dividends
| Dividend Yield | 3.02% |
| Yield on Cost 5y | 5.16% |
| Yield CAGR 5y | 19.53% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 13.7% |
| Relative Tail Risk | 3.47% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.65 |
| Alpha | 21.81 |
| Character TTM | |
|---|---|
| Beta | 0.657 |
| Beta Downside | 0.625 |
| Drawdowns 3y | |
|---|---|
| Max DD | 13.61% |
| CAGR/Max DD | 1.29 |
Description: JIRE J.P. Morgan Exchange-Traded January 08, 2026
The J.P. Morgan Exchange-Traded Fund Trust (NYSE ARCA:JIRE) is a U.S.–registered ETF that allocates at least 80 % of its capital to equity securities of companies domiciled in developed markets, aiming to beat the MSCI EAFE Index while preserving comparable sector and geographic risk profiles.
In practice, JIRE tracks the index universe but retains flexibility to hold non-index constituents, allowing the manager to capture relative value opportunities that may be under-weighted in the benchmark.
Key metrics as of the latest filing: expense ratio ≈ 0.25 %, total assets under management around $1.2 billion, and a 12-month total return of roughly +8 % (versus MSCI EAFE’s +6 %). The fund’s performance is sensitive to macro drivers such as Eurozone GDP growth, Japanese monetary policy, and commodity price trends that affect large-cap exporters in the index.
Investors should monitor the fund’s sector tilt-historically overweight in financials and information technology-and its currency exposure, which can add a 0.5-1 % drift in returns depending on USD strength.
For a deeper quantitative view, you might explore ValueRay’s analytics platform to benchmark JIRE’s risk-adjusted performance against peers.
What is the price of JIRE shares?
Over the past week, the price has changed by +2.64%, over one month by +5.30%, over three months by +11.35% and over the past year by +34.03%.
Is JIRE a buy, sell or hold?
What are the forecasts/targets for the JIRE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 97.2 | 19.8% |
JIRE Fundamental Data Overview February 10, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 10.19b USD (10.19b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 10.19b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 10.19b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.34% (E(10.19b)/V(10.19b) * Re(8.34%) + (debt-free company))
Discount Rate = 8.34% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)